Overheard: Houston's energy sector welcomes Greentown Labs

eavesdropping in Houston

Greentown Labs CEO Emily Reichert called on members of Houston's energy community to speak at Greentown Houston's grand opening. Photo by Lee Bond/Greentown Labs

Greentown Houston is officially open for business, and it's safe to say the energy innovation community is excited about it. The 40,000-square-foot space is expecting to move its inaugural 30 companies in throughout the summer.

The grand opening event, which was streamed online with an outdoor invite-only event, took place on Earth Day and featured speakers from across the energy sector. The speakers represented some of the almost 30 corporate partners Greentown Houston has announced.

Click here to read more about the grand opening and take a peek inside the facility.

Missed the discussion or just want a refresher on on the highlights? Here are some significant overheard moments from the Greentown Houston Grand Opening.

"Houston has all the necessary ingredients and it has momentum."

Photo by Lee Bond/Greentown Labs

— Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures. "Let's celebrate. And then let's get busy."

"Houston, as the energy capital of the world, has a moral obligation to reduce carbon emissions."

Photo by Lee Bond/Greentown Labs

— Mayor Sylvester Turner. "We need to invest in our innovation ecosystem and support the climatech and clean tech entrepreneurs who will be building Houston's new energy economy and creating the new jobs of tomorrow."

"Houston has the talent, know how, and can-do spirit to tackle the dual challenge of leading dual energy demand while aggressively lowering the carbon footprint."

Photo by Lee Bond/Greentown Labs

— Bob Harvey, president and CEO of the Greater Houston Partnership.

"Houston must remain the center of the future energy industry, and today is an important step in restoring that."

Photo by Natalie Harms/InnovationMap

— David Leebron, president of Rice University. "We look forward to our strong partnership."

"We can't solve climate change from the coasts. We need the whole United States to be engaged, and I'm bullish on Houston leading this transition for many reasons."

Photo by Lee Bond/Greentown Labs

— Emily Reichert, CEO of Greentown Labs. "Houston is home to world-leading energy organizations, incredible engineering strength, talent, and assets, that can, and frankly must, be redeployed to decarbonize resources."

"This is a city that does not stand still."

Photo by Lee Bond/Greentown Labs

— Ajay Mehta, General Manager of Shell. "At Shell, we have a mission to reach net zero emissions by 2050."

"For bp, partnering with Greentown Labs represents living our purpose to reimagine energy."

Photo by Lee Bond/Greentown Labs

— Jane Stricker, senior relationship manager, regions, cities and solutions at bp.

"Innovation is like oxygen, and it breathes life into hope and possibility. The work we are doing around the energy transition is hard and challenging, and frankly is going to take all of us."

Photo by Lee Bond/Greentown Labs

— Darryl Willis, corporate vice president, energy industry, at Microsoft. "We think that the future is all about partnerships and platforms, and our mission is to help from Microsoft's vantage point to accelerate the energy transition and to help the city of Houston around its aspirations around the energy transition as well."

"We appreciate being part of not only maintaining Houston's position as the energy capital of the world but also establishing it as the energy transition capital of the world."

Photo by Lee Bond/Greentown Labs

— Scott Burns, vice president of retail innovation, customer experience, and market intelligence at NRG.

"[Greentown Houston] will provide this center of gravity for the energy community to come together and work toward the transition plan."

Photo by Lee Bond/Greentown Labs

— Tim Ong, head of innovation at BHP Petroleum. "


Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Play it back: Houston home tech startup begins 2025 with fresh funding

HOUSTON INNOVATORS PODCAST EPISODE 272

One of the dozen or so Houston startups kicking of the new year with fresh funding is SmartAC.com, a company that's designed a platform that enables contractors in the HVAC and plumbing industries to monitor, manage, and optimize their maintenance memberships through advanced sensors, AI-driven diagnostics, and proactive alerts.

Last month, the SmartAC.com raised a follow-on round with support from local investor Mercury to continue growth and expansion of the product, which has evolved on many ways since the company launched in 2020, emerging from stealth with $10 million raised in a series A. In a May 2023 interview for the Houston Innovators Podcast, Founder and CEO Josh Teekell explained how he embraced the power of a pivot.

The company's sensors can monitor all aspects of air conditioning units and report back any issues, meaning homeowners have quicker and less costly repairs. While SmartAC.com started with providing the service and tech to homeowners directly, Teekell says he's had a greater interest in working with plumbers and HVAC companies who then deploy the technology to their customers.

"It became quite evident that homeowners don't care about air conditioning really at all until their system breaks," Teekell says on the show. "The technology is really built around giving those contractors as another way to gain a customer relationship and keep it."

Revisit the podcast episode below where Teekell talks about SmartAC.com's last raise.

SmartAC.com's previous round in 2023 — a $22 million series B — was used grow its team that goes out to deploy the technology and train the contractors on the platform.

"We've been very fortunate to get some of the biggest names in Houston on our cap table," Teekell says in the May 2023 conversation. "Since we're raising a bunch of money locally, everyone understands what a pain air conditioning can be."

Houston biotech company tests hard-to-fight cancer therapeutics

fighting cancer

A Houston-based, female-founded biotech company has developed a treatment that could prove to be an effective therapy for a rare blood cancer.

Cellenkos Therapeutics has completed promising Phase 1b testing of its Treg cell therapy, CK0804, in the fight against myelofibrosis. According to a news release from the Cellenkos team, the use of its cord-blood-derived therapeutics could signal a paradigm shift for the treatment of this hard-to-fight cancer.

Cellenkos was founded by MD Anderson Cancer Center physician and professor Simrit Parmar. Her research at the hospital displayed the ability of a unique subset of T cells’ capability to home in on a patient’s bone marrow, restoring immune balance, and potentially halting disease progression.

Myelofibrosis has long been treated primarily with JAK (Janus Kinase) inhibitors, medications that help to block inflammatory enzymes. They work by suppressing the immune response to the blood cancer, but don’t slow the progression of the malady. And they’re not effective for every patient.

“There is a significant need for new therapeutic options for patients living with myelofibrosis who have suboptimal responses to approved JAK inhibitors,” Parmar says. “We are greatly encouraged by the safety profile and early signs of efficacy observed in this patient cohort and look forward to continuing our evaluation of the clinical potential of CK0804 in our planned expansion cohort.”

The expansion cohort is currently enrolling patients with myelofibrosis. What exactly are sufferers dealing with? Myelofibrosis is a chronic disease that causes bone marrow to form scar tissue. This makes it difficult for the body to produce normal blood cells, leaving patients with fatigue, spleen enlargement and night sweats.

Myelofibrosis is rare, with just 16,000 to 18,500 people affected in the United States. But for patients who don’t respond well to JAKs, the prognosis could mean a shorter span than the six-year median survival rate outlined for the disease by Cleveland Clinic.

Helping myelofibrosis patients to thrive isn’t the only goal for Cellenkos right now.

The company seeks to aid people with rare conditions, particularly inflammatory and autoimmune disorders, with the use of CK0804, but also other candidates including one known as CK0801. The latter drug has shown promising efficacy in aplastic anemia, including transfusion independence in treated patients.

The company closed its $15 million series A round led by BVCF Management, based in Shanghai, in 2021. Read more here.

Pioneering Houston biotech startup expands to Brazil for next phase

On the Move

Houston biotech company Cemvita has expanded into Brazil. The company officially established a new subsidiary in the country under the same name.

According to an announcement made earlier this month, the expansion aims to capitalize on Brazil’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, which was enacted in 2024. The company said the expansion also aims to coincide with the 2025 COP30, the UN’s climate change conference, which will be hosted in Brazil in November.

Cemvita utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals.

“For decades Brazil has pioneered the bioeconomy, and now the time has come to create the future of the circular bioeconomy,” Moji Karimi, CEO of Cemvita, said in a news release. “Our vision is to combine the innovation Cemvita is known for with Brazil’s expertise and resources to create an ecosystem where waste becomes opportunity and sustainability drives growth. By joining forces with Brazilian partners, Cemvita aims to build on Brazil’s storied history in the bioeconomy while laying the groundwork for a circular and sustainable future.”

The Fuel of the Future Law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

Cemvita agreed to a 20-year contract that specified it would supply up to 50 million gallons of SAF annually to United Airlines in 2023.

"This is all made possible by our innovative technology, which transforms carbon waste into value,” Marcio Da Silva, VP of Innovation, said in a news release. “Unlike traditional methods, it requires neither a large land footprint nor clean freshwater, ensuring minimal environmental impact. At the same time, it produces high-value green chemicals—such as sustainable oils and biofuels—without competing with the critical resources needed for food production."

In 2024, Cemvita became capable of generating 500 barrels per day of sustainable oil from carbon waste at its first commercial plant. As a result, Cemvita quadrupled output at its Houston plant. The company had originally planned to reach this milestone in 2029.

---

This story originally appeared on our sister site, EnergyCapitalHTX.